Innovative drugs

Making Pharma Spain 2027

Making Pharma Spain 2027

Barcelona
Spain
Del
to
Healthcare
Innovative drugs
Industrial biotechnology
Upcoming Webinar: The Art and Science of Cyclic Peptide Drug Design: From Experimental Discovery to AI-Driven Computation and the Road Ahead

Upcoming Webinar: The Art and Science of Cyclic Peptide Drug Design: From Experimental Dis...

Del
to
Healthcare
Drug discovery
Innovative drugs
International
Digitalization
Noticia BCN Health

BCN HEALTH publishes a study evaluating the incidence, management, and associated costs of...

Healthcare
Innovative drugs
Personalized medicine
Partners
-
BCN Health
El IIBB-CSIC y Chemotargets impulsan el desarrollo de nuevas terapias contra el cáncer mediante diseño computacional de fármacos

The IIBB-CSIC and Chemotargets promote the development of new therapies against cancer t...

Healthcare
Drug discovery
Innovative drugs

The agreement combines the preclinical models developed by the Institute of Biomedical Research of Barcelona (IIBB-CSIC)...

Partners
-
Parc Científic de Barcelona
ORYZON asistirá a múltiples eventos en mayo y junio

ORYZON to participate in upcoming events in May and June

Healthcare
Drug discovery
Innovative drugs

Updated data from iadademstat’s clinical trials in acute myeloid leukemia to be presented at EHA-2026 in June.

Partners
-
Oryzon Genomics
Imnunotherapies & innovations for infectious diseases

I4ID 2026 – 10th Immunotherapies & Innovations for Infectious Diseases Congress

Lyon
France
Del
to
Healthcare
Innovative drugs
11TH BIOPRODUCTION CONGRESS

BIOPC 2026 – 11th Bioproduction Congress

Lyon
France
Del
to
Healthcare
Innovative drugs
Evento 14th antibody insdustrial symposium

AIS 2026 - 14th Antibody Industrial Symposium

Montpellier
France
Del
to
Healthcare
Innovative drugs
Acuerdo Almirall y BSC

Almirall and Barcelona Supercomputing Center expand their collaboration to accelerate inno...

Healthcare
Access to innovation
Innovative drugs

The strategic framework agreement deepens the long-standing partnership, leveraging Artificial Intelligence and High...

Partners
-
Almirall
Bandera de los Estados Unidos de América

U.S. announces pharmaceutical tariffs under Section 232: what it means for biotech compani...

Healthcare
Drug discovery
Rare diseases
Innovative drugs
Industrial biotechnology
International

At AseBio, we believe this Executive Order creates uncertainty for the European biotechnology sector—especially for...

AseBio
Subscribe to Innovative drugs